Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Anna-Barbara Moscicki, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentPediatrics
    Address3333 Calif. St,Laurel Heights
    San Francisco CA 94143
    Phone415-476-5139

       Biography 
       Education and Training
      Institution Degree School or Department Year
      University of California, San FranciscoPost-Doc Fellow/Scholar Medicine (Pediatrics)1985

       Overview 
       Interests
      Human Papillomavirus, mucosal immunity, sexually transmitted disease, physician adherence to guidelines, oral health in HIV infected children, adolescent health, eating disorders

       ORNG Applications 
       Websites
       Awarded Grants
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Moscicki AB, Puga A, Farhat S, Ma Y. Human Papillomavirus Infections in Nonsexually Active Perinatally HIV Infected Children. AIDS Patient Care STDS. 2014 Feb; 28(2):66-70.
        View in: PubMed
      2. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, Sanjosé Sd. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 31; 31 Suppl 7:H1-H31.
        View in: PubMed
      3. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, Sanjosé Sd. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 30; 31 Suppl 6:G1-G31.
        View in: PubMed
      4. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, Sanjosé Sd. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 29; 31 Suppl 5:F1-F31.
        View in: PubMed
      5. Moscicki AB, Ma Y, Farhat S, Jay J, Hanson E, Benningfield S, Jonte J, Godwin-Medina C, Wilson R, Shiboski S. Natural history of anal human papillomavirus infection in heterosexual women and risks associated with persistence. Clin Infect Dis. 2014 Mar; 58(6):804-11.
        View in: PubMed
      6. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, Sanjosé Sd. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Nov 22; 31 Suppl 8:I1-I31.
        View in: PubMed
      7. Alperen J, Brummel S, Tassiopoulos K, Mellins CA, Kacanek D, Smith R, Seage GR, Moscicki AB. Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth. J Adolesc Health. 2014 Mar; 54(3):341-9.
        View in: PubMed
      8. Garber AK, Mauldin K, Michihata N, Buckelew SM, Shafer MA, Moscicki AB. Higher calorie diets increase rate of weight gain and shorten hospital stay in hospitalized adolescents with anorexia nervosa. J Adolesc Health. 2013 Nov; 53(5):579-84.
        View in: PubMed
      9. Moscicki AB, Ma Y, Farhat S, Darragh TM, Pawlita M, Galloway DA, Shiboski S. Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16. J Infect Dis. 2013 Aug 1; 208(3):403-12.
        View in: PubMed
      10. Scott ME, Shvetsov YB, Thompson PJ, Hernandez BY, Zhu X, Wilkens LR, Killeen J, Vo DD, Moscicki AB, Goodman MT. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer. 2013 Sep 1; 133(5):1187-96.
        View in: PubMed
      11. Widdice L, Ma Y, Jonte J, Farhat S, Breland D, Shiboski S, Moscicki AB. Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis. 2013 Apr 15; 207(8):1286-94.
        View in: PubMed
      12. Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012 Dec; 120(6):1465-71.
        View in: PubMed
      13. Chan PK, Zhang C, Park JS, Smith-McCune KK, Palefsky JM, Giovannelli L, Coutlée F, Hibbitts S, Konno R, Settheetham-Ishida W, Chu TY, Ferrera A, Alejandra Picconi M, De Marco F, Woo YL, Raiol T, Piña-Sánchez P, Bae JH, Wong MC, Chirenje MZ, Magure T, Moscicki AB, Fiander AN, Capra G, Young Ki E, Tan Y, Chen Z, Burk RD, Chan MC, Cheung TH, Pim D, Banks L. Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations. Int J Cancer. 2013 Jun 1; 132(11):2528-36.
        View in: PubMed
      14. Moscicki AB, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, Kjaer SK, Palefsky J. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012 Nov 20; 30 Suppl 5:F24-33.
        View in: PubMed
      15. Denny LA, Franceschi S, de Sanjosé S, Heard I, Moscicki AB, Palefsky J. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine. 2012 Nov 20; 30 Suppl 5:F168-74.
        View in: PubMed
      16. Tassiopoulos K, Moscicki AB, Mellins C, Kacanek D, Malee K, Allison S, Hazra R, Siberry GK, Smith R, Paul M, Van Dyke RB, Seage GR. Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development. Clin Infect Dis. 2013 Jan; 56(2):283-90.
        View in: PubMed
      17. Moscicki AB, Wheeler CM, Romanowski B, Hedrick J, Gall S, Ferris D, Poncelet S, Zahaf T, Moris P, Geeraerts B, Descamps D, Schuind A. Immune responses elicited by a fourth dose of the HPV-16/18 AS04-adjuvanted vaccine in previously vaccinated adult women. Vaccine. 2012 Dec 17; 31(1):234-41.
        View in: PubMed
      18. Rubinstein ML, Shiffman S, Moscicki AB, Rait MA, Sen S, Benowitz NL. Nicotine metabolism and addiction among adolescent smokers. Addiction. 2013 Feb; 108(2):406-12.
        View in: PubMed
      19. Weinberg A, Song LY, Saah A, Brown M, Moscicki AB, Meyer WA, Bryan J, Levin MJ. Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children. J Infect Dis. 2012 Oct; 206(8):1309-18.
        View in: PubMed
      20. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012 Jul; 16(3):175-204.
        View in: PubMed
      21. Hwang LY, Ma Y, Shiboski SC, Farhat S, Jonte J, Moscicki AB. Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis. 2012 Aug 15; 206(4):504-11.
        View in: PubMed
      22. Hwang LY, Lieberman JA, Ma Y, Farhat S, Moscicki AB. Cervical ectopy and the acquisition of human papillomavirus in adolescents and young women. Obstet Gynecol. 2012 Jun; 119(6):1164-70.
        View in: PubMed
      23. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012 Apr; 137(4):516-42.
        View in: PubMed
      24. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012 May-Jun; 62(3):147-72.
        View in: PubMed
      25. Coleman HN, Moscicki AB, Farhat SN, Gupta SK, Wang X, Nakagawa M. CD8 T-cell responses in incident and prevalent human papillomavirus types 16 and 18 infections. ISRN Obstet Gynecol. 2012; 2012:854237.
        View in: PubMed
      26. Moscicki AB, Kaul R, Ma Y, Scott ME, Daud II, Bukusi EA, Shiboski S, Rebbapragada A, Huibner S, Cohen CR. Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety. J Acquir Immune Defic Syndr. 2012 Feb 1; 59(2):134-40.
        View in: PubMed
      27. Diouf K, Sawaya GF, Shiboski S, Magure T, Makunike-Mutasa R, Darragh TM, Tuveson J, Chipato T, Palefsky JM, Moscicki AB, Chirenje M, Smith-McCune K. Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol. 2011; 2011:789106.
        View in: PubMed
      28. Moscicki AB. HPV-associated cancers: it's not all about the cervix. Prev Med. 2011 Oct; 53 Suppl 1:S3-4.
        View in: PubMed
      29. Garber AK, Michihata N, Hetnal K, Shafer MA, Moscicki AB. A prospective examination of weight gain in hospitalized adolescents with anorexia nervosa on a recommended refeeding protocol. J Adolesc Health. 2012 Jan; 50(1):24-9.
        View in: PubMed
      30. Scott ME, Wilson SS, Cosentino LA, Richardson BA, Moscicki AB, Hillier SL, Herold BC. Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies. Cytokine. 2011 Nov; 56(2):430-4.
        View in: PubMed
      31. Moscicki AB, Palefsky JM. Human papillomavirus in men: an update. J Low Genit Tract Dis. 2011 Jul; 15(3):231-4.
        View in: PubMed
      32. Chan PK, Luk AC, Park JS, Smith-McCune KK, Palefsky JM, Konno R, Giovannelli L, Coutlée F, Hibbitts S, Chu TY, Settheetham-Ishida W, Picconi MA, Ferrera A, De Marco F, Woo YL, Raiol T, Piña-Sánchez P, Cheung JL, Bae JH, Chirenje MZ, Magure T, Moscicki AB, Fiander AN, Di Stefano R, Cheung TH, Yu MM, Tsui SK, Pim D, Banks L. Identification of human papillomavirus type 58 lineages and the distribution worldwide. J Infect Dis. 2011 Jun 1; 203(11):1565-73.
        View in: PubMed
      33. Mellins CA, Tassiopoulos K, Malee K, Moscicki AB, Patton D, Smith R, Usitalo A, Allison SM, Van Dyke R, Seage GR. Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS. 2011 Jul; 25(7):413-22.
        View in: PubMed
      34. Daud II, Scott ME, Ma Y, Shiboski S, Farhat S, Moscicki AB. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer. 2011 Feb 15; 128(4):879-86.
        View in: PubMed
      35. Cohen CR, Brown J, Moscicki AB, Bukusi EA, Paull JR, Price CF, Shiboski S. A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days. PLoS One. 2011; 6(1):e16258.
        View in: PubMed
      36. Rubinstein ML, Luks TL, Moscicki AB, Dryden W, Rait MA, Simpson GV. Smoking-related cue-induced brain activation in adolescent light smokers. J Adolesc Health. 2011 Jan; 48(1):7-12.
        View in: PubMed
      37. Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, Farhat S, Shiboski S. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010 Dec; 116(6):1373-80.
        View in: PubMed
      38. Hwang LY, Scott ME, Ma Y, Moscicki AB. Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol. 2011 Jan; 88(1):66-71.
        View in: PubMed
      39. Moscicki AB, Widdice L, Ma Y, Farhat S, Miller-Benningfield S, Jonte J, Jay J, de Medina CG, Hanson E, Clayton L, Shiboski S. Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling. Int J Cancer. 2010 Oct 15; 127(8):1882-92.
        View in: PubMed
      40. Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):197-204.
        View in: PubMed
      41. Cohen CR, Moscicki AB, Scott ME, Ma Y, Shiboski S, Bukusi E, Daud I, Rebbapragada A, Brown J, Kaul R. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa. AIDS. 2010 Aug 24; 24(13):2069-74.
        View in: PubMed
      42. Moscicki AB. Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev. 2010 Aug; 21(2):347-63, x-xi.
        View in: PubMed
      43. Moscicki AB, Ma Y, Jonte J, Miller-Benningfield S, Hanson E, Jay J, Godwin de Medina C, Farhat S, Clayton L, Shiboski S. The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types. Cancer Epidemiol Biomarkers Prev. 2010 Aug; 19(8):2055-65.
        View in: PubMed
      44. Smith-McCune KK, Shiboski S, Chirenje MZ, Magure T, Tuveson J, Ma Y, Da Costa M, Moscicki AB, Palefsky JM, Makunike-Mutasa R, Chipato T, van der Straten A, Sawaya GF. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One. 2010; 5(4):e10094.
        View in: PubMed
      45. Widdice LE, Breland DJ, Jonte J, Farhat S, Ma Y, Leonard AC, Moscicki AB. Human papillomavirus concordance in heterosexual couples. J Adolesc Health. 2010 Aug; 47(2):151-9.
        View in: PubMed
      46. Moscicki AB, Cox JT. Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis. 2010 Jan; 14(1):73-80.
        View in: PubMed
      47. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet. 2009 Dec 12; 374(9706):1975-85.
        View in: PubMed
      48. Fukuchi E, Sawaya GF, Chirenje M, Magure T, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki AB, Makunike-Mutasa R, Chipato T, Smith-McCune KK. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis. 2009 May; 36(5):305-11.
        View in: PubMed
      49. Farhat S, Nakagawa M, Moscicki AB. Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection. Int J Gynecol Cancer. 2009 May; 19(4):508-12.
        View in: PubMed
      50. Scott ME, Ma Y, Kuzmich L, Moscicki AB. Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3. Int J Cancer. 2009 Mar 15; 124(6):1379-83.
        View in: PubMed
      51. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. Withdrawal in adolescent light smokers following 24-hour abstinence. Nicotine Tob Res. 2009 Feb; 11(2):185-9.
        View in: PubMed
      52. Hwang LY, Ma Y, Benningfield SM, Clayton L, Hanson EN, Jay J, Jonte J, Godwin de Medina C, Moscicki AB. Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health. 2009 Feb; 44(2):103-10.
        View in: PubMed
      53. Moscicki AB. Management of adolescents who have abnormal cytology and histology. Obstet Gynecol Clin North Am. 2008 Dec; 35(4):633-43; x.
        View in: PubMed
      54. Moscicki AB, Ma Y, Wibbelsman C, Powers A, Darragh TM, Farhat S, Shaber R, Shiboski S. Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology. Obstet Gynecol. 2008 Dec; 112(6):1335-42.
        View in: PubMed
      55. Sawaya GF, Chirenje MZ, Magure MT, Tuveson JL, Ma Y, Shiboski SC, Da Costa MM, Palefsky JM, Moscicki AB, Mutasa RM, Chipato T, Smith-McCune KK. Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial. Obstet Gynecol. 2008 Nov; 112(5):990-7.
        View in: PubMed
      56. Moscicki AB. Vaginal microbicides: where are we and where are we going? J Infect Chemother. 2008 Oct; 14(5):337-41.
        View in: PubMed
      57. Moscicki AB. HPV Vaccines: today and in the Future. J Adolesc Health. 2008 Oct; 43(4 Suppl):S26-40.
        View in: PubMed
      58. Moscicki AB, Smith JS. Issues in human papillomavirus vaccination in adolescents. J Adolesc Health. 2008 Oct; 43(4 Suppl):S1-4.
        View in: PubMed
      59. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. Pediatrics. 2008 Sep; 122(3):e643-7.
        View in: PubMed
      60. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics. 2008 Sep; 122(3):e595-600.
        View in: PubMed
      61. Widdice LE, Moscicki AB. Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents. J Adolesc Health. 2008 Oct; 43(4 Suppl):S41-51.
        View in: PubMed
      62. Wang X, Moscicki AB, Tsang L, Brockman A, Nakagawa M. Memory T cells specific for novel human papillomavirus type 16 (HPV16) E6 epitopes in women whose HPV16 infection has become undetectable. Clin Vaccine Immunol. 2008 Jun; 15(6):937-45.
        View in: PubMed
      63. Diem K, Spitzer M, Twiggs LB, Cox J, Kaufman RH, Moscicki AB, Rubin M. A 23-year-old woman has her first Pap smear, thin prep smear interpreted as "high grade squamous intraepithelial lesion". J Low Genit Tract Dis. 2008 Jan; 12(1):54-8.
        View in: PubMed
      64. Moscicki AB. Conservative management of adolescents with abnormal cytology and histology. J Natl Compr Canc Netw. 2008 Jan; 6(1):101-6.
        View in: PubMed
      65. Lieberman JA, Moscicki AB, Sumerel JL, Ma Y, Scott ME. Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates. Clin Vaccine Immunol. 2008 Jan; 15(1):49-54.
        View in: PubMed
      66. Rubinstein ML, Thompson PJ, Benowitz NL, Shiffman S, Moscicki AB. Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res. 2007 Jan; 9(1):129-35.
        View in: PubMed
      67. Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007 Jan-Feb; 57(1):7-28.
        View in: PubMed
      68. Moscicki AB. HPV infections in adolescents. Dis Markers. 2007; 23(4):229-34.
        View in: PubMed
      69. Nakagawa M, Kim KH, Gillam TM, Moscicki AB. HLA class I binding promiscuity of the CD8 T-cell epitopes of human papillomavirus type 16 E6 protein. J Virol. 2007 Feb; 81(3):1412-23.
        View in: PubMed
      70. Smith-McCune KK, Tuveson JL, Rubin MM, Da Costa MM, Darragh TM, Shiboski SC, Van Der Pol B, Moscicki AB, Palefsky JM, Sawaya GF. Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis. 2006 Oct; 10(4):213-8.
        View in: PubMed
      71. Casper C, Meier AS, Wald A, Morrow RA, Corey L, Moscicki AB. Human herpesvirus 8 infection among adolescents in the REACH cohort. Arch Pediatr Adolesc Med. 2006 Sep; 160(9):937-42.
        View in: PubMed
      72. Moscicki AB, Ellenberg JH, Murphy DA, Jiahong X. Associations among body composition, androgen levels, and human immunodeficiency virus status in adolescents. J Adolesc Health. 2006 Aug; 39(2):164-73.
        View in: PubMed
      73. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/42-51.
        View in: PubMed
      74. Scott ME, Ma Y, Farhat S, Shiboski S, Moscicki AB. Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking. J Clin Immunol. 2006 May; 26(3):222-32.
        View in: PubMed
      75. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006 Apr 15; 367(9518):1247-55.
        View in: PubMed
      76. Frazer IH, Cox JT, Mayeaux EJ, Franco EL, Moscicki AB, Palefsky JM, Ferris DG, Ferenczy AS, Villa LL. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatr Infect Dis J. 2006 Feb; 25(2 Suppl):S65-81, quiz S82.
        View in: PubMed
      77. Moscicki AB. Impact of HPV infection in adolescent populations. J Adolesc Health. 2005 Dec; 37(6 Suppl):S3-9.
        View in: PubMed
      78. Moscicki AB. Cervical cytology testing in teens. Curr Opin Obstet Gynecol. 2005 Oct; 17(5):471-5.
        View in: PubMed
      79. Nakagawa M, Kim KH, Moscicki AB. Patterns of CD8 T-cell epitopes within the human papillomavirus type 16 (HPV 16) E6 protein among young women whose HPV 16 infection has become undetectable. Clin Diagn Lab Immunol. 2005 Aug; 12(8):1003-5.
        View in: PubMed
      80. Moscicki AB. Human papilloma virus, papanicolaou smears, and the college female. Pediatr Clin North Am. 2005 Feb; 52(1):163-77, ix.
        View in: PubMed
      81. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton KL, Farhat S, Broering JM, Darragh TM. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004 Nov 6-12; 364(9446):1678-83.
        View in: PubMed
      82. Moscicki AB, Ellenberg JH, Crowley-Nowick P, Darragh TM, Xu J, Fahrat S. Risk of high-grade squamous intraepithelial lesion in HIV-infected adolescents. J Infect Dis. 2004 Oct 15; 190(8):1413-21.
        View in: PubMed
      83. Nakagawa M, Kim KH, Moscicki AB. Different methods of identifying new antigenic epitopes of human papillomavirus type 16 E6 and E7 proteins. Clin Diagn Lab Immunol. 2004 Sep; 11(5):889-96.
        View in: PubMed
      84. Moscicki AB, Ellenberg JH, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis. 2004 Jul 1; 190(1):37-45.
        View in: PubMed
      85. Wilson CM, Ellenberg JH, Douglas SD, Moscicki AB, Holland CA. CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population. AIDS Res Hum Retroviruses. 2004 Mar; 20(3):263-9.
        View in: PubMed
      86. Moscicki AB. Cervical cytology screening in teens. Curr Womens Health Rep. 2003 Dec; 3(6):433-7.
        View in: PubMed
      87. Douglas SD, Durako S, Sullivan KE, Camarca M, Moscicki AB, Wilson CM. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Clin Diagn Lab Immunol. 2003 May; 10(3):399-404.
        View in: PubMed
      88. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American cancer society guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis. 2003 Apr; 7(2):67-86.
        View in: PubMed
      89. Moscicki AB, Durako SJ, Ma Y, Darragh T, Vermund SH. Utility of cervicography in HIV-infected and uninfected adolescents. J Adolesc Health. 2003 Mar; 32(3):204-13.
        View in: PubMed
      90. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003 Mar; 157(3):249-55.
        View in: PubMed
      91. Moscicki AB, Durako SJ, Houser J, Ma Y, Murphy DA, Darragh TM, Farhat S, Wilson CM. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS. 2003 Feb 14; 17(3):311-20.
        View in: PubMed
      92. Straub DM, Hills NK, Thompson PJ, Moscicki AB. Effects of pro- and anti-tobacco advertising on nonsmoking adolescents' intentions to smoke. J Adolesc Health. 2003 Jan; 32(1):36-43.
        View in: PubMed
      93. Rubin MM, Moscicki AB, Twiggs LB. Human papillomavirus infection of the cervix in a 14-year-old girl. J Low Genit Tract Dis. 2003 Jan; 7(1):51-2.
        View in: PubMed
      94. Nichter M, Nichter M, Thompson PJ, Shiffman S, Moscicki AB. Using qualitative research to inform survey development on nicotine dependence among adolescents. Drug Alcohol Depend. 2002 Nov; 68 Suppl 1:S41-56.
        View in: PubMed
      95. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002 Nov-Dec; 52(6):342-62.
        View in: PubMed
      96. Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, Fukumoto L. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. 2002 Oct 15; 35(Suppl 2):S210-24.
        View in: PubMed
      97. Rudy BJ, Wilson CM, Durako S, Moscicki AB, Muenz L, Douglas SD. Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH project. Clin Diagn Lab Immunol. 2002 Sep; 9(5):959-65.
        View in: PubMed
      98. Nakagawa M, Viscidi R, Deshmukh I, Costa MD, Palefsky JM, Farhat S, Moscicki AB. Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women. Clin Diagn Lab Immunol. 2002 Jul; 9(4):877-82.
        View in: PubMed
      99. Shiboski CH, Wilson CM, Greenspan D, Hilton J, Greenspan JS, Moscicki AB. HIV-related oral manifestations among adolescents in a multicenter cohort study. J Adolesc Health. 2001 Sep; 29(3 Suppl):109-14.
        View in: PubMed
      100. Vermund SH, Wilson CM, Rogers AS, Partlow C, Moscicki AB. Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health. 2001 Sep; 29(3 Suppl):49-56.
        View in: PubMed
      101. Murphy DA, Durako SJ, Moscicki AB, Vermund SH, Ma Y, Schwarz DF, Muenz LR. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health. 2001 Sep; 29(3 Suppl):57-63.
        View in: PubMed
      102. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001 Jun 20; 285(23):2995-3002.
        View in: PubMed
      103. Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 2001 Mar; 8(2):209-20.
        View in: PubMed
      104. Moscicki AB, Ma Y, Holland C, Vermund SH. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis. 2001 Mar 15; 183(6):865-70.
        View in: PubMed
      105. Schlecht NF, Franco EL, Rohan TE, Kjaer SK, Schiffman MH, Moscicki AB, Duffy SW. Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: determinants of reporting error at follow-up interviews. J Epidemiol Biostat. 2001; 6(5):393-407.
        View in: PubMed
      106. Murphy DA, Moscicki AB, Vermund SH, Muenz LR. Psychological distress among HIV(+) adolescents in the REACH study: effects of life stress, social support, and coping. The Adolescent Medicine HIV/AIDS Research Network. J Adolesc Health. 2000 Dec; 27(6):391-8.
        View in: PubMed
      107. Jay N, Moscicki AB. Human papillomavirus infections in women with HIV disease: prevalence, risk, and management. AIDS Read. 2000 Nov; 10(11):659-68.
        View in: PubMed
      108. Nakagawa M, Stites DP, Patel S, Farhat S, Scott M, Hills NK, Palefsky JM, Moscicki AB. Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis. 2000 Aug; 182(2):595-8.
        View in: PubMed
      109. Holland CA, Ellenberg JH, Wilson CM, Douglas SD, Futterman DC, Kingsley LA, Moscicki AB. Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network. AIDS Res Hum Retroviruses. 2000 Jul 1; 16(10):959-63.
        View in: PubMed
      110. Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis. 2000 Mar; 181(3):939-45.
        View in: PubMed
      111. Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000 Feb; 154(2):127-34.
        View in: PubMed
      112. Douglas SD, Rudy B, Muenz L, Moscicki AB, Wilson CM, Holland C, Crowley-Nowick P, Vermund SH. Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. Adolescent Medicine HIV/AIDS Research Network. AIDS. 1999 Sep 10; 13(13):1629-35.
        View in: PubMed
      113. Scott M, Stites DP, Moscicki AB. Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol. 1999 Sep; 6(5):751-5.
        View in: PubMed
      114. Moscicki AB. Human papillomavirus infection in adolescents. Pediatr Clin North Am. 1999 Aug; 46(4):783-807.
        View in: PubMed
      115. Nakagawa M, Stites DP, Palefsky JM, Kneass Z, Moscicki AB. CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses. Clin Diagn Lab Immunol. 1999 Jul; 6(4):494-8.
        View in: PubMed
      116. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer. 1999 Mar 1; 85(5):1139-44.
        View in: PubMed
      117. Moscicki AB, Hills NK, Shiboski S, Darragh TM, Jay N, Powell K, Hanson E, Miller SB, Farhat S, Palefsky J. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev. 1999 Feb; 8(2):173-8.
        View in: PubMed
      118. Phillips SA, Moscicki AB, Kaufman M, Moore E. The composition of SAM: development of diversity. Society for Adolescent Medicine. J Adolesc Health. 1998 Dec; 23(6 Suppl):162-5.
        View in: PubMed
      119. Moscicki AB. Genital infections with human papillomavirus (HPV). Pediatr Infect Dis J. 1998 Jul; 17(7):651-2.
        View in: PubMed
      120. Rogers AS, Futterman DK, Moscicki AB, Wilson CM, Ellenberg J, Vermund SH. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. J Adolesc Health. 1998 Apr; 22(4):300-11.
        View in: PubMed
      121. Lappa ST, Coleman MT, Moscicki AB. Managing sexually transmitted diseases in adolescents. Prim Care. 1998 Mar; 25(1):71-110.
        View in: PubMed
      122. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998 Feb; 132(2):277-84.
        View in: PubMed
      123. Lappa S, Moscicki AB. The pediatrician and the sexually active adolescent. A primer for sexually transmitted diseases. Pediatr Clin North Am. 1997 Dec; 44(6):1405-45.
        View in: PubMed
      124. Nakagawa M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F, Moscicki AB, Palefsky JM. Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis. 1997 Apr; 175(4):927-31.
        View in: PubMed
      125. Ramirez JE, Ramos DM, Clayton L, Kanowitz S, Moscicki AB. Genital human papillomavirus infections: knowledge, perception of risk, and actual risk in a nonclinic population of young women. J Womens Health. 1997 Feb; 6(1):113-21.
        View in: PubMed
      126. Moscicki AB. Genital HPV infections in children and adolescents. Obstet Gynecol Clin North Am. 1996 Sep; 23(3):675-97.
        View in: PubMed
      127. Nakagawa M, Stites DP, Farhat S, Judd A, Moscicki AB, Canchola AJ, Hilton JF, Palefsky JM. T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia. Clin Diagn Lab Immunol. 1996 Mar; 3(2):205-10.
        View in: PubMed
      128. Millstein SG, Moscicki AB. Sexually-transmitted disease in female adolescents: effects of psychosocial factors and high risk behaviors. J Adolesc Health. 1995 Aug; 17(2):83-90.
        View in: PubMed
      129. Moscicki AB, Hunter SD, Garland S, Quinn M, Crowe SM, Shortman K, Stites D. A simple method for the propagation of cervical lymphocytes. Clin Diagn Lab Immunol. 1995 Jan; 2(1):40-3.
        View in: PubMed
      130. Ford CA, Moscicki AB. Control of sexually transmitted diseases in adolescents: the clinician's role. Adv Pediatr Infect Dis. 1995; 10:263-305.
        View in: PubMed
      131. Moscicka A, Gadzinowski J, Moscicki A, Breborowicz GH, Opala T. [Usefulness of transcutaneous measurements of bilirubin in infants with jaundice]. Ginekol Pol. 1994 Jun; 65(6):271-5.
        View in: PubMed
      132. Millstein SG, Moscicki AB, Broering JM. Female adolescents at high, moderate, and low risk of exposure to HIV: differences in knowledge, beliefs, and behavior. J Adolesc Health. 1994 Mar; 15(2):133-41.
        View in: PubMed
      133. Siadat-Pajouh M, Periasamy A, Ayscue AH, Moscicki AB, Palefsky JM, Walton L, DeMars LR, Power JD, Herman B, Lockett SJ. Detection of human papillomavirus type 16/18 DNA in cervicovaginal cells by fluorescence based in situ hybridization and automated image cytometry. Cytometry. 1994 Mar 1; 15(3):245-57.
        View in: PubMed
      134. Ellen JM, Moscicki AB, Shafer MA. Genital herpes simplex virus and human papillomavirus infection. Adv Pediatr Infect Dis. 1994; 9:97-124.
        View in: PubMed
      135. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol. 1993 Oct; 82(4 Pt 1):578-85.
        View in: PubMed
      136. Slomko Z, Malewski Z, Moscicki A, Musial T. [Delivery in adolescence]. Ginekol Pol. 1993 Aug; 64(8):412-7.
        View in: PubMed
      137. Moscicki AB, Millstein SG, Broering J, Irwin CE. Risks of human immunodeficiency virus infection among adolescents attending three diverse clinics. J Pediatr. 1993 May; 122(5 Pt 1):813-20.
        View in: PubMed
      138. Moscicki AB, Broering J, Powell K, Klein J, Clayton L, Smith G, Boero S, Darragh TM, Brescia RJ, Palefsky J. Comparison between colposcopic, cytologic, and histologic findings in women positive and negative for human papillomavirus DNA. J Adolesc Health. 1993 Mar; 14(2):74-9.
        View in: PubMed
      139. Moscicki AB. Comparison between methods for human papillomavirus DNA testing: a model for self-testing in young women. J Infect Dis. 1993 Mar; 167(3):723-5.
        View in: PubMed
      140. Moscicki AB, Palefsky JM, Gonzales J, Smith G, Schoolnik GK. Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA. J Infect Dis. 1992 Nov; 166(5):951-7.
        View in: PubMed
      141. Moscicki AB. Human papillomavirus infections. Adv Pediatr. 1992; 39:257-81.
        View in: PubMed
      142. Moscicki AB, Palefsky JM, Gonzales J, Schoolnik GK. The association between human papillomavirus deoxyribonucleic acid status and the results of cytologic rescreening tests in young, sexually active women. Am J Obstet Gynecol. 1991 Jul; 165(1):67-71.
        View in: PubMed
      143. Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res. 1990 Nov; 28(5):507-13.
        View in: PubMed
      144. Shafer MA, Schachter J, Moscicki AB, Weiss A, Shalwitz J, Vaughan E, Millstein SG. Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA. 1989 Nov 10; 262(18):2562-6.
        View in: PubMed
      145. Moscicki AB, Winkler B, Irwin CE, Schachter J. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia. J Pediatr. 1989 Sep; 115(3):487-93.
        View in: PubMed
      146. Moscicki AB, Shafer MA. Normal reproductive development in the adolescent female. J Adolesc Health Care. 1986 Nov; 7(6 Suppl):41S-64S.
        View in: PubMed
      Anna-Barbara's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP